General
Preferred name
BUFOGENIN
Synonyms
Recibufogenin ()
Resibufogenin ()
Bufogenin, Recibufogenin ()
NSC-90783 ()
Bufogenina ()
Bufogenine ()
P&D ID
PD072706
CAS
465-39-4
Tags
available
drug
Drug Status
approved
investigational
Max Phase
2.0
Structure
BUFOGENIN
approved
RO5
MW
384.23
HBA
4
HBD
1
RB
1
LOGP
4.26
5
9
0
0
Structure formats
SMILES
C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)C[C@H]3O[C@@]312
InChI
InChI=1S/C24H32O4/c1-22-9-7-16(25)11-15(22)4-5-18-17(22)8-10-23(2)19(12-20-24(18,23)28-20)14-3-6-21(26)27-13-14/h3,6,13,15-20,25H,4-5,7-12H2,1-2H3/t15-,16+,17+,18-,19-,20-,22+,23-,24-/m1/s1
InChIkey
ATLJNLYIJOCWJE-CWMZOUAVSA-N
MOL
BUFOGENIN RDKit 2D 28 33 0 0 0 0 0 0 0 0999 V2000 0.0580 -4.6881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4846 -4.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1727 -5.6918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2874 -6.6955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7140 -6.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8287 -7.2357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.0259 -4.7648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9111 -3.7611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2230 -2.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1083 -1.2902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6817 -1.7537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3698 -3.2209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0567 -3.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1715 -2.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8596 -1.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3268 -1.5254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7413 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2413 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9913 1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4913 1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.2413 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.7413 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.4913 -1.2990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.9913 -1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8596 1.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4330 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8660 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4330 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 1 5 7 1 0 8 7 1 6 8 9 1 0 9 10 1 0 11 10 1 6 11 12 1 0 12 13 1 1 13 14 1 0 14 15 1 0 15 16 1 1 15 17 1 0 17 18 1 1 18 19 1 0 19 20 2 0 20 21 1 0 21 22 2 0 21 23 1 0 23 24 1 0 17 25 1 0 26 25 1 1 26 27 1 0 28 27 1 1 8 2 1 0 28 11 1 0 12 2 1 0 28 15 1 0 24 18 2 0 28 26 1 0 M END > <ID> PD072706 > <Name> BUFOGENIN
Protein targets
0
Target pathways
0
References
3
2013 C23 steroids from the venom of Bufo bufo gargarizans.
Tian HY, Luo SL et al. J. Nat. Prod.
2007 Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
Zhang J, Sun Y et al. Bioorg. Med. Chem. Lett.
2004 Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells.
Enomoto A, Rho MC et al. J. Nat. Prod.
Cell lines
3
5.1
BGC-823
4.64
MH60
4.36
HepG2
Organisms
0
Compound Sets
9
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Available from
6
Cayman Chemical Bioactives
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
25
PubChem 6917974
ACToR 465-39-4
ChEBI 31319
ChemicalBook CB6254472
ChemSpider 5293192
DrugCentral 3523
eMolecules 29780514
FDA SRS 3K654P2M4J
LipidMaps LMST01130031
Nikkaji J2.050H
NMRShiftDB 70016026
PDB 6JI
PubChem DOTF 12013885
PubChem TPS 16676903
Reactome 5293192
SureChEMBL SCHEMBL309405
Properties
(calculated by RDKit )
Molecular Weight
384.23
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
1
Ring Count
6
Aromatic Ring Count
1
cLogP
4.26
TPSA
62.97
Fraction CSP3
0.79
Chiral centers
9.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Na/K-ATPase inhibitor
Target
Akt,Apoptosis related,Bcl-2,Caspase,CDK,GSK-3,Mixed Lineage Kinase,PI3K,RIP kinase,ROS,Wnt/beta-catenin
Source data